The largest database of trusted experimental protocols

Glucose oxidase method

Manufactured by Yellow Springs Instruments
Sourced in United States

The glucose oxidase method is a laboratory technique used to measure the concentration of glucose in a sample. It involves the use of the enzyme glucose oxidase, which catalyzes the oxidation of glucose to gluconic acid and hydrogen peroxide. The amount of hydrogen peroxide produced is then measured, which is proportional to the glucose concentration in the sample.

Automatically generated - may contain errors

9 protocols using glucose oxidase method

1

Predicting Prediabetes Intervention Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whenever blood, plasma, or serum from humans was analyzed, we took data from subjects at risk of future development of type 2 diabetes taking part of the TUebingen Lifestyle Intervention Program (TULIP). The TULIP study was designed to find parameters that predict the effect of a lifestyle intervention with diet and moderate increase in aerobic physical activity to improve prediabetes phenotypes and the cardiovascular risk profile [34 (link),35 (link)]. The participants underwent a standard 75-g oral glucose tolerance test (OGTT). Venous plasma samples were obtained at 0, 30, 60, 90, and 120 min for determination of plasma glucose and insulin. Blood glucose was determined using a bedside glucose analyzer (glucose-oxidase method; YSI, Yellow Springs Instruments, Yellow Springs, OH, USA). The study was approved by the local research ethics committee, and written informed consent was obtained from all participants.
+ Open protocol
+ Expand
2

Blood Sampling and Metabolic Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
All blood sampling was done via an indwelling catheter. Plasma glucose concentration was analyzed by the glucose oxidase method (Yellow Springs Instruments, Ohio)[35 (link)]. Plasma immunoreactive insulin concentration was determined with a double antibody radioimmunoassay (Diagnostic, Webster, TX)[36 ]. Serum cholesterol (Total-C, HDL-C) and Triglycerides (TG) were determined by standard enzymatic procedures (Sigma, St. Louis, MO). Assays of HbA1c were performed using an DCA Vantage analyzer (Siemens, Germany)[37 (link)].
+ Open protocol
+ Expand
3

Plasma Metabolite Measurement Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma samples were placed on ice, centrifuged at 4°C, separated and then stored at −20°C until assayed. Glucose concentrations were measured using the glucose oxidase method (Yellow Springs Instruments, Yellow Springs, OH, USA). Plasma insulin was measured using a chemiluminescence assay (Access Assay; Beckman, Chaska, MN, USA). Plasma glucagon and C-peptide concentrations were measured by Radio-Immunoassay (Linco Research, St Louis, MO, USA). Plasma [6,6-2H2]glucose and [1-13C]glucose enrichments were measured using gas chromatographic MS (Thermoquest, San Jose, CA, USA) to simultaneously monitor C-1 plus C-2 and C-3 – C-6 fragments, as described by Beylot et al [23 (link)]. In addition, [6-3H]glucose specific activity was measured by liquid scintillation counting after deproteinisation and anion exchange and cation exchange chromatography.
+ Open protocol
+ Expand
4

Glucose and Isotope Tracer Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma samples were placed on ice, centrifuged at 4°C, separated, and stored at −20°C until assay. Glucose concentrations were measured using a glucose oxidase method (Yellow Springs Instruments, Yellow Springs, OH). Plasma insulin was measured using a chemiluminescence assay with reagents obtained from Beckman (Access Assay; Beckman, Chaska, MN). Plasma glucagon and C-peptide were measured by radioimmunoassay using reagents supplied by Linco Research (St. Louis, MO). Plasma [6,6-2H2]glucose and [1-13C]glucose enrichments were measured using gas chromatography–mass spectrometry (Thermoquest, San Jose, CA) to simultaneously monitor the C-1, C-2, and C-3 to C-6 fragments, as described by Beylot et al. [30 (link)]. [6-3H]glucose specific activity was measured by liquid scintillation counting following deproteinization and passage over anion- and cation-exchange columns.
+ Open protocol
+ Expand
5

Plasma Glucose and Hormone Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma samples were placed on ice, centrifuged at 4°C, separated, and stored at −20°C until assayed. Glucose concentrations were measured from dorsal vein samples using a glucose oxidase method (Yellow Springs Instruments, Yellow Springs, OH). Plasma insulin was measured from hepatic vein samples using a chemiluminescence assay (Access Assay; Beckman, Chaska, MN). Plasma glucagon was measured from hepatic vein samples by Radioimmunoassay (Linco Research, St. Louis, MO).
+ Open protocol
+ Expand
6

Fescue Seed Nutrient Analysis and Hormone Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Feed samples were analyzed for nutrient content by a commercial laboratory (North Carolina Department of Agriculture, Raleigh, NC). Concentration of total alkaloids in the fescue seed was analyzed by a commercial laboratory (Agrinostics Ltd. Co., Watkinsville, GA) using an ELISA (Hill and Agee, 1994 (link)). Ergovaline concentration in the fescue seed was analyzed by a commercial laboratory (University of Missouri Veterinary Medical Diagnostic Laboratory, Colombia, MO) using HPLC (Rottinghaus et al., 1991 , 1993 (link)). Serum prolactin (Bernard et al., 1993 (link)) and serum insulin (Cartiff et al., 2013 (link)) were determined by radioimmunoassay. For prolactin, the intra-assay CV was 6.8% and the inter-assay CV was 7.1%. For insulin, the intra-assay CV was 5.5% and the inter-assay CV was 8.4%. Plasma glucose was analyzed using a glucose oxidase method (Yellow Springs Instruments, Yellow Springs, OH). Concentration of hentriacontane in feed and fecal samples and calculation of DM digestibility in Experiment 1 were determined as described by Chavez et al. (2011 (link)).
+ Open protocol
+ Expand
7

Isotopic Glucose Kinetics Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma samples were placed on ice, centrifuged at 4°C, separated, and stored at −20°C until assayed. Glucose concentrations were measured using a glucose oxidase method (Yellow Springs Instruments, Yellow Springs, OH). Plasma insulin was measured using a chemiluminescence assay (Access Assay; Beckman, Chaska, MN). Plasma glucagon and C-peptide were measured by Radio-Immunoassay (Linco Research, St. Louis, MO). Collection tubes for GLP-1 had 100 μmol/L dipeptidyl peptidase-4 inhibitor (Linco Research, St. Louis, MO) added. Total GLP-1 concentrations were measured using a COOH-terminal assay (Linco Research). Plasma [6,6-2H2]glucose and [1-13C]glucose enrichments were measured using gas chromatographic mass spectrometry (Thermoquest, San Jose, CA) to simultaneously monitor the C-1 and C-2 and C-3 to C-6 fragments, as described by Beylot et al. (22 (link)). In addition, [6-3H]glucose specific activity was measured by liquid scintillation counting after deproteinization and passage over anion- and cation-exchange columns (20 (link)).
+ Open protocol
+ Expand
8

Detailed Metabolic Biomarker Assessments

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma glucose was measured using a glucose oxidase method (Yellow Springs Instruments Co, Yellow Springs, Ohio, USA). Hemoglobin A1c (HbA1c), fasting plasma lipid profiles and urinary albumin and creatinine levels were measured in a contract clinical laboratory using standard methodologies. Plasma insulin was measured in our Endocrine Research Laboratory using a chemiluminescent assay, using commercial kits (Immulite, Siemens, Llanberis, Gwynedd, UK). The sensitivity of the insulin assay was 2 μIU/mL and the within-run and between-run coefficients of variation were 4.7% and 8%, respectively.
+ Open protocol
+ Expand
9

Metabolic Biomarker Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum cholesterol (total, low-density lipoprotein (LDL), and high-density lipoprotein (HDL)), triglycerides, aspartate transaminase (AST), alanine aminotransferase (ALT), and gamma glutamyl transferase (γ-GT) were assessed using a Cobas 8000 analyzer (Roche, Basel, Switzerland). Plasma glucose was measured using the glucose oxidase method (YSI, Yellow Springs Instruments, Yellow Springs, CO, USA). Serum C-peptide and insulin levels were quantified using the respective radio-immunoassays from Millipore (St. Charles, MO, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!